SANTOS HELENA R 4

What Happened
Helena R. Santos, President & CEO and a director of Scientific Industries, was granted 130,000 derivative shares (transaction code A) on February 17, 2026. The award shows an acquisition price of $0.00 (i.e., a non‑cash stock award or unit grant). This is a compensation award rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-02-17; reported on Form 4 filed 2026-04-01.
• Price: $0.00 per share (derivative award/grant).
• Shares involved: 130,000 awarded.
• Shares owned after transaction: Not stated in this filing.
• Footnote: Vesting is subject to a 4‑year cliff from the date of the option/grant (no vesting until the cliff period completes).
• Timeliness: The Form 4 was filed ~6 weeks after the transaction date; Form 4s are normally due within two business days of the reportable transaction, so this appears to be a late filing.

Context
Because this is a derivative award (A), it functions as compensation tying the CEO to company performance/retention rather than a market purchase that signals personal buying conviction. The 4‑year cliff means the award won’t vest incrementally — shares (or exercisable rights) typically become available only after four years, subject to the grant terms. Delayed filing is a compliance note investors may want to consider when evaluating insider reporting.